
Medical Product Regulatory Affairs: Pharmaceuticals, Diagnostics, Medical Devices, 2nd Edition
Medical Product Regulatory Affairs is a practical reference covering regulatory affairs for pharmaceuticals, diagnostics and medical devices across major global markets. This second edition addresses EU medical-device regulations and topics including product development, clinical trials, manufacturing licences and US regulatory processes.
At a glance
- Covers pharmaceuticals, diagnostics and medical devices, with regulatory topics across major global markets.
- Includes regulatory strategy, drug development, non-clinical studies and clinical trials.
- Discusses national and EU regulatory processes, US regulation, manufacturing licences and good practice frameworks.
- The second edition includes coverage of new EU regulations on medical-device safety, according to the listing.
Reference price: $194.95
Price checked: 18 Nov 2026
View offerAhead of Black FridayExplore the selectionPros and cons
Pros
- Broad subject coverage can suit readers seeking one reference spanning several medical-product categories and regulatory markets.
- The listed contents connect regulatory policy with development, manufacturing, quality systems and clinical-trial processes.
Technical specifications
9 specifications| Publisher | Wiley-VCH |
|---|---|
| Edition | 2nd |
| Publication date | 11 October 2023 |
| Language | English |
| Print length | 336 pages |
| ISBN-10 | 3527333266 |
| ISBN-13 | 978-3527333264 |
| Weight listed | 771 g |
|---|---|
| Dimensions | 2 x 17 x 24 cm |
Who is it for?
A good fit for
- Regulatory-affairs professionals seeking a reference across pharmaceutical and medical-device topics.
- Pharmacologists, bioengineers, pharmaceutical engineers and pharmacy students building familiarity with regulation.
- Academic or industry training courses covering global product regulation.
Less suited to
- Readers seeking a guide limited to one country's current regulations or one product category.
Customer reviews on Amazon
- 5 stars
50% 50% - 4 stars
50% 50% - 3 stars
0% 0% - 2 stars
0% 0% - 1 star
0% 0%
Aggregate ratings are split between four- and five-star categories, with no lower-star ratings shown in the supplied distribution. This is a small rating sample and does not establish specific strengths or criticisms. Consider the book's broad market coverage and publication date when deciding whether it suits your needs, particularly if you require current jurisdiction-specific guidance.
Frequently asked questions
What topics does this book cover?
The listing describes coverage of pharmaceuticals, diagnostics and medical devices, including drug development, regulatory strategy, clinical trials, manufacturing and regulation in the EU and USA.
Which edition is listed?
The listed edition is the second edition, published on 11 October 2023.
Who may find it useful?
The listing identifies regulatory-affairs professionals, pharmacologists, bioengineers, pharmaceutical engineers, pharmacy students and training courses as potential audiences.
Is this a country-specific regulatory manual?
The listing describes coverage across major global markets, with national and EU issues and regulation in the USA. It does not establish that the book is a substitute for checking current rules in a particular jurisdiction.























